P3 Health Partners Files 8-K: Material Agreement & Exhibits
Ticker: PIIIW · Form: 8-K · Filed: Aug 29, 2025 · CIK: 1832511
| Field | Detail |
|---|---|
| Company | P3 Health Partners Inc. (PIIIW) |
| Form Type | 8-K |
| Filed Date | Aug 29, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $5,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-reporting, corporate-action
TL;DR
P3 Health Partners inked a big deal, filing material agreements and financials.
AI Summary
On August 27, 2025, P3 Health Partners Inc. filed an 8-K report. The filing indicates an entry into a material definitive agreement and includes financial statements and exhibits. The company, formerly known as Foresight Acquisition Corp., is incorporated in Delaware and headquartered in Henderson, Nevada.
Why It Matters
This filing signals a significant contractual development for P3 Health Partners Inc., potentially impacting its operations and financial standing.
Risk Assessment
Risk Level: medium — The filing of a material definitive agreement suggests a significant business event that could carry inherent risks and opportunities for the company.
Key Numbers
- 001-40033 — Commission File Number (Identifies the company's SEC filing record.)
- 85-2992794 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- P3 Health Partners Inc. (company) — Registrant
- August 27, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Henderson, Nevada (location) — Principal executive offices
- Foresight Acquisition Corp. (company) — Former company name
FAQ
What type of material definitive agreement did P3 Health Partners Inc. enter into?
The filing does not specify the exact nature of the material definitive agreement, only that one was entered into on or before August 27, 2025.
When was P3 Health Partners Inc. formerly known as Foresight Acquisition Corp.?
The filing indicates that the company was formerly known as Foresight Acquisition Corp. and the date of the name change is not explicitly stated in this excerpt, but the 8-K is filed in 2025.
Where are P3 Health Partners Inc.'s principal executive offices located?
P3 Health Partners Inc.'s principal executive offices are located at 2370 Corporate Circle Suite 300, Henderson, Nevada 89074.
What is the SEC Act under which this report is filed?
This report is filed under the Securities Exchange Act of 1934.
What are the main items reported in this 8-K filing?
This 8-K filing reports on the 'Entry into a Material Definitive Agreement' and 'Financial Statements and Exhibits'.
Filing Stats: 694 words · 3 min read · ~2 pages · Grade level 14.2 · Accepted 2025-08-29 16:17:12
Key Financial Figures
- $0.0001 — stered Class A common stock, par value $0.0001 per share PIII The Nasdaq Stock Market
- $5,000,000 — nging the principal payments to a fixed $5,000,000 per payment date; changes the interest
Filing Documents
- piii-20250827.htm (8-K) — 30KB
- piii-20250827exhibit101.htm (EX-10.1) — 70KB
- piii-20250827_g1.jpg (GRAPHIC) — 201KB
- 0001832511-25-000015.txt ( ) — 732KB
- piii-20250827.xsd (EX-101.SCH) — 2KB
- piii-20250827_def.xml (EX-101.DEF) — 15KB
- piii-20250827_lab.xml (EX-101.LAB) — 26KB
- piii-20250827_pre.xml (EX-101.PRE) — 16KB
- piii-20250827_htm.xml (XML) — 4KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. On August 27, 2025, P3 Health Group, LLC ("P3 LLC"), a subsidiary of P3 Health Partners Inc. (the "Company") entered into the Tenth Amendment (the "Amendment") to that certain Term Loan Agreement, dated as of November 19, 2020, by and among P3 LLC, as borrower, the subsidiary guarantors party thereto, the lenders from time to time party thereto, and CRG Servicing LLC, as administrative agent and collateral agent (as amended, the "Term Loan Agreement"). The Amendment: amends the payment structure of the Term Loan Agreement by extending the interest-only period to September 30, 2026, extending the maturity date to December 31, 2027, and changing the principal payments to a fixed $5,000,000 per payment date; changes the interest rate from 12% to 12% through December 31, 2025 and 15% thereafter; includes two separate Paid In-Kind ("PIK") periods, replacing the previous single PIK period: the first PIK Period measures from closing of the Term Loan Agreement through December 31, 2024 and includes the option to pay 8% cash plus 4% PIK (added to the principal); and the second PIK Period measures from January 1, 2026 through December 31, 2027 and includes the option to pay 12% cash plus 3% PIK; and updates board observation rights for lender representatives. The Amendment also includes standard conditions precedent for effectiveness and reaffirmation of existing loan obligations. The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by the terms of the Amendment, a copy of which is filed herewith as Exhibit 10.1 and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 10 .1 Tenth Amendment to Term Loan Agreement, dated as of August 27, 2025, by and among P3 Health Group, LLC, as borrower, the Subsidiary Guarantors party thereto, the Lenders party thereto, and CRG Servicing LLC, as administrative agent and collateral agent. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. P3 Health Partners Inc. Date: August 29, 2025 By: /s/ Leif Pedersen Leif Pedersen Chief Financial Officer